Proposed federal cuts could reduce funds for health, agriculture and education research on the island. #NewsismyBusiness
The Agriculture Division of DowDuPont, which was formed by the merger of Dow Chemical and DuPont, announced plans for strategic realignment of its business by combining its resources that will increase Research and Development capacity in Puerto Rico.
Technology-based small businesses are constantly contending for a competitive advantage by introducing new products, technologies and solutions, or improving their existing capabilities.
Since 2015, the Puerto Rico Science, Technology and Research Trust has assisted more than 100 local researchers with its Research Grants Program, which has awarded close to $6 million in grants for projects in science and technology, institution officials said Wednesday.
A study released by the Puerto Rico Statistics Institute showed that Research & Development investments during Fiscal 2015 were $443.3 million, or to 0.43 percent of the island’s GDP. This represents a slight 1.3 percent drop compared to Fiscal 2013.
The Puerto Rico Science, Technology and Research Trust presented the five scientist winners of the Small Research Grants Program, an initiative through which funds are awarded to help them position their respective research and development proposals in a more competitive realm, prior to being submitted for consideration by federal and private agencies.
Toyota Motor Corp. announced Monday it will establish a new company, Toyota Research Institute Inc., as an R&D enterprise with an initial focus on artificial intelligence and robotics, in Silicon Valley.
Investments made in Puerto Rico by companies performing research and development activities totaled $449.3 million in Fiscal 2013, up 3.3 percent in comparison to the total reported in 2009, the Puerto Rico Statistics Institute revealed.
It was five years ago that manufacturing giant GlaxoSmithKline North America Pharmaceuticals took a step back to assess the way it was doing business.
The Puerto Rico Science, Research and Technology Trust and the government’s Chief Information Officer will work together to identify and evaluate research and development projects of high economic impact, which in turn may generate new marketable technologies, the entities announced Sunday.
CDI Laboratories in Mayagüez — the only company in the world using pioneering technology with the ability to generate high specificity monoclonal antibodies — began a new phase of research after receiving a combined $11.4 million in local and federal funding to develop new technologies in the field of medicine.
Looking to foster Puerto Rico’s potential in pharmaceutical innovation, drug developer Merck has partnered with the Yale School of Medicine and the Comprehensive Cancer Center at the University of Puerto Rico to launch a drug discovery and development teaching program.
Puerto Rico Puerto, the second largest investment destination in the region, is struggling to retain its position as a “viable value proposition” for pharmaceutical companies that have significantly scaled back their investments on the island in the last four years, a recently released study by Jones Lang LaSalle a global real estate services firm concluded.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA